Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: A systematic review and meta-analysis
Voriconazole exposure and longer duration of voriconazole were found to be significantly associated with increased risk of squamous cell carcinoma. Regular dermatologic surveillance should be considered for the patients taking voriconazole, especially those at high risk of developing squamous cell carcinoma.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Huilin Tang, Weilong Shi, Yiqing Song, Jiali Han Source Type: research
More News: Academies | Cancer & Oncology | Carcinoma | Dermatology | Lung Transplant | Skin | Skin Cancer | Squamous Cell Carcinoma | Transplant Surgery | Transplants